Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds
NeutralFinancial Markets

Hims & Hers Health reported its Q3 2025 earnings, which fell short of expectations for earnings per share (EPS). Despite this setback, the company's stock showed signs of recovery following the announcement. This is significant as it reflects investor confidence in the company's long-term potential, even in the face of disappointing quarterly results.
— Curated by the World Pulse Now AI Editorial System












